Local 12: UC startup gains approval for trials
Portable system from Sense Neuro Diagnostics can detect brain injuires
Medtech startup Sense Neuro Diagnostics is developing the system, NeuSTAT, to help medical personnel diagnose everything from a traumatic brain injury in battle to a stroke.
“NeuSTAT is a device which will detect blood and for the trial, it’ll be approved to detect blood for someone who may have had a hemorrhagic stroke or bleeding from a traumatic brain injury,” Geoff Klass, CEO of Sense Neuro Diagnostics, said. “Worldwide, there's 50 billion traumatic brain injuries each year, and if you have a traumatic brain injury or if you have a stroke, immediate care is important.”
Sense Neuro Diagnostics hopes for results from the initial trial this year.
Featured image at top: Model of a brain. Photo by Robina Weermeijer on Unsplash
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.